Pregabalin Open-Label Add-On Trial: An Open-Label, Multicenter Follow-On Study to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.
Latest Information Update: 14 Nov 2009
At a glance
- Drugs Pregabalin (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Sponsors Pfizer
- 29 Sep 2006 Status change
- 08 Feb 2006 New trial record.